Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)
crossref（2023）
摘要
Supplementary Figure 8: (A) PFS and (B) OS of patients based on BRAF mutant allele frequency (>= vs. < median).
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要